CGIM
MRNA icon

Capital Group Investment Management’s Moderna MRNA Stock Holding History

Capital Group Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,627
Closed -$375K – 196
2023
Q3 		$375K Buy
3,627
+1,107
+44% +$123K 0.02% 184
2023
Q2 		$306K Sell
2,520
-899
-26% -$120K 0.02% 193
2023
Q1 		$525K Buy
3,419
+1,352
+65% +$223K 0.03% 180
2022
Q4 		$371K Buy
+2,067
New +$338K 0.01% 195

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Group Investment Management's MRNA Position: Q4 2023 in Review

Capital Group Investment Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 3,627 shares — an estimated $375K sold.

Capital Group Investment Management first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $525K in Q1 2023. 885 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Capital Group Investment Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Capital Group Investment Management sold 3,627 Moderna shares in Q4 2023, an estimated $375K.
  • Capital Group Investment Management first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • Capital Group Investment Management's Moderna position peaked at $525K in Q1 2023.
  • 885 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Capital Group Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.